Identification of a transmission chain of HIV type 1 containing drug resistance-associated mutations

AIDS Research and Human Retroviruses

Volumn 19, Issue 5, 2003, Pages 353-361

  Taylor, Stephen ^a,b   Ratcliffe, Daina ^a   Choudhury, Bhudipa ^a   Pillay, Deenan ^a,d   Cane, Patricia ^a   Hué, Stéphane ^a   Xu, Li ^a   Wrin, Terri ^c   Lie, Yolanda ^c   Hellmann, Nicholas ^c   Petropoulos, Christos ^c   Workman, Judith ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^c MONOGRAM BIOSCIENCES   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DIDANOSINE; EFAVIRENZ; HYDROXYUREA; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; RITONAVIR; RNA DIRECTED DNA POLYMERASE; SAQUINAVIR; STAVUDINE;

ARTICLE; CASE REPORT; ENVELOPE GENE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRIORITY JOURNAL; VIRUS MUTATION; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HOMOSEXUALITY, MALE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PHENOTYPE; PHYLOGENY; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; SEMEN; SEQUENCE ANALYSIS, DNA; ZIDOVUDINE;

EID: 0038182982     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203765551700     Document Type: Article

References (46)

1. Boden D, Hurley A, Zhang L, Cao Y, Guo Y, Jones E, et al.: HIV-1 drug resistance in newly infected individuals. JAMA 1999;282:1135-1141.
2. Brenner B, Routy JP, Petrella M, Moisi D, Oliveira MD, Spira B, et al.: Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection. J Virol 2002;76:1753-1761.
3. Briones C, Perez-Olmeda M, Rodriguez C, del Romero J, Hertogs K, and Soriano V: Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid. J Acquit Immune Defic Syndr 2001;26:145-150.
4. Little SJ, Daar ES, D'Aquila RT, Keiser PH, Connick E, Whitcomb JM, et al.: Reduced antiretroviral drug susceptibility among patients with primary HIV infection. JAMA 1999;282:1142-1149.
5. UK Resistance Collaborative Group: Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom. BMJ 2001;322:1087-1088.
6. Anderson RM and May RM: Infectious Diseases of Humans - Dynamics and Control. Oxford University Press, Oxford, 1992.
7. Colgrove RC, Pitt J, Chung PH, Welles SL, and Japour AJ: Selective vertical transmission of HIV-1 antiretroviral resistance mutations. AIDS 1998;12:2281-2288.
8. Wahlberg J, Fiore J, Angarano G, Uhlen M, and Albert J: Apparent selection against transmission of zidovudine-resistant human immunodeficiency virus type 1 variants. J Infect Dis 1994;169:611-614.
9. Blower SM, Aschenbach AN, Gershengorn HB, and Kahn JO: Predicting the unpredictable: Transmission of drug-resistant HIV. Nat Med 2001;7:1016-1020.
10. Goudsmit J, Weverling GJ, van der HL, de Ronde A, Miedema F, Coutinho RA, et al.: Carrier rate of zidovudine-resistant HIV-1: The impact of failing therapy on transmission of resistant strains. AIDS 2001;15:2293-2301.
11. Leigh Brown AJ, Frost SDW, Mathews WC, et al.: Will transmission of drug resistant HIV be driven by individuals infected with drug resistant strains? In: 9th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, 2002 [abstract 367-M].
12. de Ronde A, van Dooren M, van der HL, Bouwhuis D, de Rooij E, van Gemen B, et al.: Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus. J Virol 2001;75:595-602.
13. Yerly S, Rakik A, De LS, Hirschel B, Descamps D, Brun-Vezinet F, et al.: Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants. J Virol 1998;72:3520-3523.
14. Pillay D, Cane PA, Shirley J, and Porter K: Detection of drug resistance in HIV primary infection within the UK. AIDS 2000;14:906-908.
15. Garcia-Lerma JG, Nidtha S, Blumoff K, Weinstock H, and Heneine W: Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons. Proc Natl Acad Sci USA 2001;98:13907-13912.
16. Holmes EC, Zhang LQ, Simmonds P, Rogers AS, and Brown AJ: Molecular investigation of human immunodeficiency virus (HIV) infection in a patient of an HIV-infected surgeon. J Infect Dis 1993;167:1411-1414.
17. Sheehy N, Desselberger U, Whitwell H, and Ball JK: Concurrent evolution of regions of the envelope and polymerase genes of human immunodeficiency virus type 1 during zidovudine (AZT) therapy. J Gen Virol 1996;77:1071-1081.
18. Schafer R, et al.: Stanford HIV Resistance Data Base (1999). http://hivdb.stanford.edu.
19. Deeks SG, Wrin T, Liegler T, Hoh R, Hayden M, Barbour JD, et al.: Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. N Engl J Med 2001;344:472-480.
20. Albert J, Wahlberg J, Leitner T, Escanilla D, and Uhlen M: Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes. J Virol 1994;68:5918-5924.
21. Arnold C, Balfe P, and Clewley JP: Sequence distances between env genes of HIV-1 from individuals infected from the same source: Implications for the investigation of possible transmission events. Virology 1995;211:198-203.
22. Crandall KA: Intraspecific phylogenetics: Support for dental transmission of human immunodeficiency virus. J Virol 1995;69:2351-2356.
23. Holmes EC, Zhang LQ, Robertson P, Cleland A, Harvey E, Simmonds P, et al.: The molecular epidemiology of human immunodeficiency virus type 1 in Edinburgh. J Infect Dis 1995;171:45-53.
24. Leitner T, Escanilla D, Franzen C, Uhlen M, and Albert J: Accurate reconstruction of a known HIV-1 transmission history by phylogenetic tree analysis. Proc Natl Acad Sci USA 1996;93:10864-10869.
25. Balfe P, Simmonds P, Ludlam CA, Bishop JO, and Brown AJ: Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations. J Virol 1990;64:6221-6233.
26. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, and Higgins DG: The CLUSTAL X Windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997;25:4876-4882.
27. GeneDoc: Multiple Sequence Alignment Editor and Shading Utility (1997). http://www.psc.edu/biomed/genedoc.
28. Kumar, et al: Molecular Evolutionary Genetics Analysis software. Arizona State University, Tempe, Arizona, 2001.
29. Strimmer K and von Haeseler A: Likelihood-mapping: A simple method to visualise phylogenetic content of a sequence alignment. Proc Natl Acad Sci USA 1997;94:6815-6819.
30. PAUP*: Phylogenetic Analysis Using Parsimony (and Other Methods), version 4. Sinauer Associates, Sunderland, Massachusetts, 2000.
31. Felsenstein J. Phylogenies from molecular sequences: Inference and reliability. Annu Rev Genet 1988;22:521-565.
32. Tamalet C, Pasquier C, Yahi N, Colson P, Poizot-Martin I, Lepeu G, et al.: Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection. J Med Virol 2000;61:181-186.
33. Weinstock H, Respess R, Heneine W, Petropoulos CJ, Hellmann NS, Luo CC, et al.: Prevalence of mutations associated with reduced antiretroviral drug susceptibility among human immunodeficiency virus type 1 seroconverters in the United States, 1993-1998. J Infect Dis 2000;182:330-333.
34. Yerly S, Kaiser L, Race E, Bru JP, Clavel F, and Perrin L: Transmission of antiretroviral-drug-resistant HIV-1 variants. Lancet 1999;354:729-733.
35. Salomon H, Wainberg MA, Brenner B, Quan Y, Rouleau D, Cote P, et al.: Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study. AIDS 2000;14:F17-F23.
36. Balotta C, Berlusconi A, Pan A, Violin M, Riva C, Colombo MC, et al.: Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: Outcome after treatment in recently infected individuals. Antiviral Ther 2000;5:7-14.
37. Devereux HL, Youle M, Johnson MA, and Loveday C: Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy. AIDS 1999;13:F123-F127.
38. Byrn RA and Kiessling AA: Analysis of human immunodeficiency virus in semen: Indications of a genetically distinct virus reservoir. J Reprod Immunol 1998;41:161-176.
39. Eron JJ, Vernazza PL, Johnston DM, Seillier-Moiseiwitsch F, Alcorn TM, Fiscus SA, et al.: Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: Implications for transmission. AIDS 1998;12:F181-F189.
40. Eyre RC, Zheng G, and Kiessling AA: Multiple drug resistance mutations in human immunodeficiency virus in semen but not blood of a man on antiretroviral therapy. Urology 2000;55:591.
41. Zhu T, Wang N, Carr Z, Nam DS, Moor-Jankowski R, Cooper DA, et al.: Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: Evidence for viral compartmentalization and selection during sexual transmission. J Virol 1996;70:3098-3107.
42. Delwart EL, Mullins JI, Gupta P, Learn GH, Jr., Holodniy M, Katzenstein D, et al.: Human immunodeficiency virus type 1 populations in blood and semen. J Virol 1998;72:617-623.
43. Taylor S and Pereira AS: Antiretroviral drug concentrations in semen of HIV-1 infected men. Sex Transm Infect 2001;77:4-11.
44. Taylor S, Back DJ, Drake SM, Workman J, Reynolds H, Gibbons SE, et al.: Antiretroviral drug concentrations in semen of HIV-infected men: Differential penetration of indinavir, ritonavir and saquinavir. J Antimicrob Chemother 2001;48:351-354.
45. Hecht FM, Grant RM, Petropoulos CJ, Dillon B, Chesney MA, Tian H, et al.: Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med 1998;339:307-311.
46. Romano L, Venturi G, Vivarelli A, Galli L, and Zazzi M: Detection of a drug-resistant human immunodeficiency virus variant in a newly infected heterosexual couple. Clin Infect Dis 2002;34:116-117.